The supercritical antisolvent (SAS) technique has been widely employed in the biomedical
field, including drug delivery, to obtain drug particles or polymer-based systems of …

Many active ingredients currently prescribed show limited therapeutic efficacy, mainly due to
their dissolution rate inadequate to treat the pathology of interest. A large drug particle size …

The low aqueous solubility and subsequently slow dissolution rate, as well as the poor
bioavailability of several active pharmaceutical ingredients (APIs), are major challenges in …

Whey‐based nutritional beverages are often fortified with calcium (Ca) in order to deliver the
recommended intake of Ca. However, technical and product quality challenges are often …

Myricetin (MYR) shows a lot of pharmacological activity such as antioxidant capacity and
antitumor activity. However, the poor aqueous solubility of MYR (2 μg/mL) limits its …

This review focuses on nanoparticle (NP) synthesis and particle size design using
supercritical fluid (SCF) technology for pharmaceutical formulations. SCF technology is seen …

The production of fine particles via the supercritical carbon dioxide (SC–CO2) antisolvent
process was carried out. The experiments were conducted at temperatures of 40–60° C and …

For dissolution enhancement of celecoxib (CLX), an anti-solvent crystallization technique in
the presence of polyvinylpyrrolidone (PVP) was applied by either water (WAS), a …

The term “nutraceutical” was coined in 1989 by the Foundation for Innovation in Medicine
(New York, US; an educational foundation to encourage discoveries in medicine). A …

Glibenclamide is an antidiabetic drug that also acts as an anti-inflammatory factor and
reduces oxidative stress, medullary edema, and heart attack. Glibenclamide has high …